Henry Schein (HSIC) Free Cash Flow Growth (3y) (2012 - 2026)
Henry Schein (HSIC) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 0.80% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 30.60% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 10.23% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -212.44% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -45.61% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -3.17% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -22.47% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 44.68% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -212.44% |
| Dec 27, 2025 | 14.53% |
| Sep 27, 2025 | 23.97% |
| Jun 28, 2025 | -12.86% |
| Mar 29, 2025 | -56.72% |
| Dec 28, 2024 | -12.06% |
| Sep 28, 2024 | -15.51% |
| Jun 29, 2024 | 22.47% |
| Mar 30, 2024 | 47.11% |
| Dec 30, 2023 | -30.25% |
| Sep 30, 2023 | -9.15% |
| Jul 1, 2023 | 63.82% |
| Apr 1, 2023 | -27.49% |
| Dec 31, 2022 | -19.52% |
| Sep 24, 2022 | -29.79% |
| Jun 25, 2022 | 109.07% |
| Mar 26, 2022 | -14.26% |
| Dec 25, 2021 | -14.37% |
| Sep 25, 2021 | 79.72% |
| Jun 26, 2021 | -18.96% |